Wanbangde Pharmaceutical Holding Group Co., Ltd. (SZSE: 002082)
Health Care · Pharmaceuticals · CN
CN¥12.97
+8.08% today · +6.2% 1Y
Wanbangde Pharmaceutical Holding Group Co., Ltd. (SZSE: 002082) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.18B and employs 1,348 people.
Over the last twelve months the share price has gained 6.2%, trading between 8.53 and 36.24.
Tweenvest scores Wanbangde Pharmaceutical Holding Group Co., Ltd. across four factors: quality 62/100, value 34/100, growth 0/100. Its strongest factor is quality.
002082 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.18B
- Revenue (TTM)
- $166.00M
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- -0.07
- 52-week high
- CN¥36.24
- 52-week low
- CN¥8.53
- Avg volume (3M)
- —
- Shares outstanding
- 611.69M
- Employees
- 1,348
- Next earnings
- —
About Wanbangde Pharmaceutical Holding Group Co., Ltd.
Established in 1985 and headquartered in Taizhou, China, Wanbangde Pharmaceutical Holding Group Co., Ltd. primarily focuses on the research, development, manufacturing, and distribution of traditional Chinese medicines, active pharmaceutical ingredients (APIs), and various medicinal preparations. The company also extends its operations into the medical technology field, developing products such as orthopedic implant devices, general medical equipment, protective gear, and disposable sterile polymer medical consumables. Complementary to its product offerings, it provides specialized hospital engineering services. Initially known as Wanbangde New Building Materials Co., Ltd., the company officially adopted its current name, Wanbangde Pharmaceutical Holding Group Co., Ltd., in April 2020.
- ISIN
- CNE000001P94
- Founded
- 1985
- Listed since
- Nov 20, 2006
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.20B | CN¥39.40 | -1.38% |
| Sichuan Huiyu Pharmaceutical Co., Ltd.SHSE: 688553 | $1.19B | CN¥12.85 | +4.81% |
| LB Pharmaceuticals IncNasdaqGM: LBRX | $1.19B | $34.61 | -6.43% |
| Cronos Group Inc.TSX: CRON | $1.18B | CA$4.58 | -0.87% |
| Zhejiang Tianyu Pharmaceutical Co., Ltd.SZSE: 300702 | $1.17B | CN¥22.68 | +6.48% |
| Sawai Group Holdings Co., Ltd.TSE: 4887 | $1.17B | ¥1,589.00 | -4.65% |
| Beijing Foyou Pharma CO.,LTDSHSE: 601089 | $1.15B | CN¥16.48 | +3.78% |
| Harrow, Inc.NasdaqGM: HROW | $1.14B | $30.52 | -0.33% |
Figures last refreshed Oct 4, 2026.